Please choose an event type to view the corresponding MedsFacts report:

INTERSTITIAL LUNG DISEASE ( 20 FDA reports)
CARDIAC FAILURE ( 9 FDA reports)
VENTRICULAR TACHYCARDIA ( 8 FDA reports)
CONDITION AGGRAVATED ( 7 FDA reports)
RESPIRATORY FAILURE ( 7 FDA reports)
ALANINE AMINOTRANSFERASE INCREASED ( 6 FDA reports)
BLOOD LACTATE DEHYDROGENASE INCREASED ( 6 FDA reports)
CARDIAC FAILURE CONGESTIVE ( 6 FDA reports)
PLEURAL EFFUSION ( 6 FDA reports)
ASPARTATE AMINOTRANSFERASE INCREASED ( 5 FDA reports)
DRUG INEFFECTIVE ( 5 FDA reports)
LIVER DISORDER ( 5 FDA reports)
ANAEMIA ( 4 FDA reports)
ANOREXIA ( 4 FDA reports)
ATRIAL FIBRILLATION ( 4 FDA reports)
BLOOD ALKALINE PHOSPHATASE INCREASED ( 4 FDA reports)
HEPATIC FUNCTION ABNORMAL ( 4 FDA reports)
CARDIAC ARREST ( 3 FDA reports)
CARDIOGENIC SHOCK ( 3 FDA reports)
CARDIOMEGALY ( 3 FDA reports)
CELL MARKER INCREASED ( 3 FDA reports)
CEREBRAL INFARCTION ( 3 FDA reports)
DRUG INTERACTION ( 3 FDA reports)
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED ( 3 FDA reports)
ELECTROCARDIOGRAM QT PROLONGED ( 3 FDA reports)
GAMMA-GLUTAMYLTRANSFERASE INCREASED ( 3 FDA reports)
HEPATIC FAILURE ( 3 FDA reports)
HYPERTHYROIDISM ( 3 FDA reports)
INFECTION ( 3 FDA reports)
PARALYSIS ( 3 FDA reports)
PULMONARY CONGESTION ( 3 FDA reports)
PULMONARY OEDEMA ( 3 FDA reports)
RENAL FAILURE ( 3 FDA reports)
SEPSIS ( 3 FDA reports)
SYNCOPE ( 3 FDA reports)
VENTRICULAR FIBRILLATION ( 3 FDA reports)
WHITE BLOOD CELL COUNT DECREASED ( 3 FDA reports)
BLOOD BILIRUBIN INCREASED ( 2 FDA reports)
BLOOD UREA INCREASED ( 2 FDA reports)
CEREBRAL ARTERY EMBOLISM ( 2 FDA reports)
CHEST DISCOMFORT ( 2 FDA reports)
DECREASED APPETITE ( 2 FDA reports)
DEHYDRATION ( 2 FDA reports)
DIALYSIS ( 2 FDA reports)
DRUG ERUPTION ( 2 FDA reports)
HAEMATOCRIT DECREASED ( 2 FDA reports)
HAEMODIALYSIS ( 2 FDA reports)
HAEMOGLOBIN DECREASED ( 2 FDA reports)
HYPOGLYCAEMIA ( 2 FDA reports)
HYPOTHYROIDISM ( 2 FDA reports)
METABOLIC ACIDOSIS ( 2 FDA reports)
NONSPECIFIC REACTION ( 2 FDA reports)
PANCREATITIS ACUTE ( 2 FDA reports)
PNEUMONIA ASPIRATION ( 2 FDA reports)
PNEUMONIA BACTERIAL ( 2 FDA reports)
PULMONARY HAEMORRHAGE ( 2 FDA reports)
SHOCK ( 2 FDA reports)
SINUS ARREST ( 2 FDA reports)
STAPHYLOCOCCAL INFECTION ( 2 FDA reports)
THROMBOCYTOPENIA ( 2 FDA reports)
THYROIDITIS ( 2 FDA reports)
VOMITING ( 2 FDA reports)
ACQUIRED DIAPHRAGMATIC EVENTRATION ( 1 FDA reports)
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED ( 1 FDA reports)
ADRENAL INSUFFICIENCY ( 1 FDA reports)
ADVERSE DRUG REACTION ( 1 FDA reports)
ARRHYTHMIA ( 1 FDA reports)
ATRIAL FLUTTER ( 1 FDA reports)
BILE DUCT STENOSIS ( 1 FDA reports)
BILIARY DILATATION ( 1 FDA reports)
BLOOD BICARBONATE INCREASED ( 1 FDA reports)
BLOOD CALCIUM INCREASED ( 1 FDA reports)
BLOOD CHLORIDE DECREASED ( 1 FDA reports)
BLOOD CHLORIDE INCREASED ( 1 FDA reports)
BLOOD CHOLESTEROL INCREASED ( 1 FDA reports)
BLOOD CREATININE INCREASED ( 1 FDA reports)
BLOOD GLUCOSE INCREASED ( 1 FDA reports)
BLOOD LACTATE DEHYDROGENASE ( 1 FDA reports)
BLOOD PH DECREASED ( 1 FDA reports)
BLOOD PRESSURE DECREASED ( 1 FDA reports)
BLOOD SODIUM INCREASED ( 1 FDA reports)
BODY TEMPERATURE DECREASED ( 1 FDA reports)
BRADYCARDIA ( 1 FDA reports)
BRAIN NATRIURETIC PEPTIDE INCREASED ( 1 FDA reports)
BRONCHOPNEUMONIA ( 1 FDA reports)
C-REACTIVE PROTEIN INCREASED ( 1 FDA reports)
CARBOHYDRATE ANTIGEN 19-9 INCREASED ( 1 FDA reports)
CARDIAC DISORDER ( 1 FDA reports)
CARDIOACTIVE DRUG LEVEL ABOVE THERAPEUTIC ( 1 FDA reports)
CONGESTIVE CARDIOMYOPATHY ( 1 FDA reports)
CRYPTOGENIC ORGANISING PNEUMONIA ( 1 FDA reports)
CRYPTOGENIC ORGANIZING PNEUMONIA ( 1 FDA reports)
DIARRHOEA ( 1 FDA reports)
DISEASE RECURRENCE ( 1 FDA reports)
DISSEMINATED INTRAVASCULAR COAGULATION ( 1 FDA reports)
DRUG LEVEL ABOVE THERAPEUTIC ( 1 FDA reports)
DRUG LEVEL INCREASED ( 1 FDA reports)
EOSINOPHILIA ( 1 FDA reports)
EPISTAXIS ( 1 FDA reports)
FIBRIN D DIMER INCREASED ( 1 FDA reports)
FIBRIN DEGRADATION PRODUCTS INCREASED ( 1 FDA reports)
GAIT DISTURBANCE ( 1 FDA reports)
GASTROENTERITIS VIRAL ( 1 FDA reports)
GENERAL PHYSICAL HEALTH DETERIORATION ( 1 FDA reports)
GLOMERULONEPHRITIS ( 1 FDA reports)
GLYCOSYLATED HAEMOGLOBIN INCREASED ( 1 FDA reports)
GRANULOCYTOPENIA ( 1 FDA reports)
HAEMOPTYSIS ( 1 FDA reports)
HEART RATE INCREASED ( 1 FDA reports)
HEPATIC CIRRHOSIS ( 1 FDA reports)
HYPERTENSION ( 1 FDA reports)
HYPERTROPHIC CARDIOMYOPATHY ( 1 FDA reports)
HYPONATRAEMIA ( 1 FDA reports)
IMPLANTABLE DEFIBRILLATOR MALFUNCTION ( 1 FDA reports)
INFLAMMATION ( 1 FDA reports)
INTERNATIONAL NORMALISED RATIO DECREASED ( 1 FDA reports)
INTERNATIONAL NORMALISED RATIO INCREASED ( 1 FDA reports)
INTESTINAL PERFORATION ( 1 FDA reports)
IRON DEFICIENCY ANAEMIA ( 1 FDA reports)
JAUNDICE ( 1 FDA reports)
JAUNDICE CHOLESTATIC ( 1 FDA reports)
KERATOPATHY ( 1 FDA reports)
LEUKOCYTOSIS ( 1 FDA reports)
LUNG ABSCESS ( 1 FDA reports)
LUNG DISORDER ( 1 FDA reports)
LUNG INFECTION ( 1 FDA reports)
MALAISE ( 1 FDA reports)
MALIGNANT NEOPLASM PROGRESSION ( 1 FDA reports)
METASTASES TO LYMPH NODES ( 1 FDA reports)
MULTI-ORGAN FAILURE ( 1 FDA reports)
MULTIPLE MYELOMA ( 1 FDA reports)
MUSCULAR WEAKNESS ( 1 FDA reports)
NEUTROPHIL COUNT DECREASED ( 1 FDA reports)
NODAL RHYTHM ( 1 FDA reports)
OPPORTUNISTIC INFECTION ( 1 FDA reports)
OPTIC NERVE CUPPING ( 1 FDA reports)
PANCREATIC CARCINOMA METASTATIC ( 1 FDA reports)
PANCREATIC DUCT DILATATION ( 1 FDA reports)
PANCREATIC DUCT OBSTRUCTION ( 1 FDA reports)
PCO2 DECREASED ( 1 FDA reports)
PERITONITIS ( 1 FDA reports)
PLATELET COUNT DECREASED ( 1 FDA reports)
PNEUMONIA ( 1 FDA reports)
PNEUMONIA PRIMARY ATYPICAL ( 1 FDA reports)
PNEUMOTHORAX ( 1 FDA reports)
PO2 INCREASED ( 1 FDA reports)
PROCEDURAL COMPLICATION ( 1 FDA reports)
PROTHROMBIN TIME PROLONGED ( 1 FDA reports)
PSEUDOMONAS INFECTION ( 1 FDA reports)
PULMONARY ALVEOLAR HAEMORRHAGE ( 1 FDA reports)
PYREXIA ( 1 FDA reports)
RENAL FAILURE CHRONIC ( 1 FDA reports)
RESPIRATORY ARREST ( 1 FDA reports)
SEPTIC SHOCK ( 1 FDA reports)
SICK SINUS SYNDROME ( 1 FDA reports)
STAPHYLOCOCCAL SEPSIS ( 1 FDA reports)
THERAPY NON-RESPONDER ( 1 FDA reports)
THYROID GLAND CANCER ( 1 FDA reports)
TORSADE DE POINTES ( 1 FDA reports)
TUMOUR MARKER INCREASED ( 1 FDA reports)
URINE OUTPUT DECREASED ( 1 FDA reports)
VENTRICULAR DYSFUNCTION ( 1 FDA reports)
VISUAL FIELD DEFECT ( 1 FDA reports)
WOUND DEHISCENCE ( 1 FDA reports)

© 2014 MedsFacts, Inc
Privacy Policy
Terms of Use